Pulmonary Fibrosis News

Pulmonary Fibrosis News We are dedicated to sharing the latest news, research, and pulmonary fibrosis patient perspectives.

Taladegib has been granted orphan drug designation in the U.S. and the European Union as a treatment for idiopathic pulm...
07/18/2025

Taladegib has been granted orphan drug designation in the U.S. and the European Union as a treatment for idiopathic pulmonary fibrosis. https://buff.ly/SYKwyfY

Columnist Sam Kirton had to make some adjustments after his IPF diagnosis, but there are still plenty of ways to find jo...
07/15/2025

Columnist Sam Kirton had to make some adjustments after his IPF diagnosis, but there are still plenty of ways to find joy, he says. https://buff.ly/nOjlX7C

GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial. htt...
07/11/2025

GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial. https://buff.ly/9TggTc1

Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and h...
07/10/2025

Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and his donor's legacy. https://buff.ly/WdjRnrp

Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnis...
07/01/2025

Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton. https://buff.ly/6yEm92f

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary f...
06/27/2025

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis. https://buff.ly/9GJuNtF

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to particip...
06/24/2025

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them. https://buff.ly/qL18G7j

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the...
06/20/2025

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the fight against PF. https://buff.ly/YvV1WOs

Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough en...
06/18/2025

Living with pulmonary fibrosis, columnist Ann Reynoso writes, means no more independent, spontaneous days with enough energy for everything. https://buff.ly/Ey7wjCv

During the dog days of summer, columnist Sam Kirton takes special care to protect himself from medication side effects. ...
06/17/2025

During the dog days of summer, columnist Sam Kirton takes special care to protect himself from medication side effects. https://buff.ly/bJHEwbz

In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency ...
06/13/2025

In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency after six weeks. https://buff.ly/XNw8AwU

Columnist Sam Kirton, calling the PF world an inclusive community, promotes care for those LGBTQIA+ while appealing to t...
06/10/2025

Columnist Sam Kirton, calling the PF world an inclusive community, promotes care for those LGBTQIA+ while appealing to them to donate organs. https://buff.ly/yqhQ3DA

Address

University Park, TX

Alerts

Be the first to know and let us send you an email when Pulmonary Fibrosis News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pulmonary Fibrosis News:

Share

JOIN THE PF FORUMS!

WHY YOU SHOULD CONSIDER JOINING OUR ONLINE FORUM?

It’s a safe community to connect with other patients.

You can get comprehensive updates on PF in one place.

We welcome physicians and researchers, patients and caregivers.